Global Over the Counter (OTC) & Diet Supplementary market size is predicted to grow from US$ 160410 million in 2025 to US$ 227760 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031. Get Access Now!

Global Over the Counter (OTC) & Diet Supplementary Market Size and Outlook 2025-31

The global Over the Counter (OTC) & Diet Supplementary market size is predicted to grow from US$ 160410 million in 2025 to US$ 227760 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. OTC and diet supplements are non-prescription products intended for health support, including vitamins, minerals, and herbal supplements. Wellness and preventive health are driving the demand for OTC and diet supplements. Personalized and functional supplements are gaining popularity. Infinity Market Research newest research report, the Over the Counter (OTC) & Diet Supplementary Industry Forecast looks at past sales and reviews total world Over the Counter (OTC) & Diet Supplementary sales in 2024, providing a comprehensive analysis by region and market sector of projected Over the Counter (OTC) & Diet Supplementary sales for 2025 through 2031. With Over the Counter (OTC) & Diet Supplementary sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Over the Counter (OTC) & Diet Supplementary industry. This Insight Report provides a comprehensive analysis of the global Over the Counter (OTC) & Diet Supplementary landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Over the Counter (OTC) & Diet Supplementary portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Over the Counter (OTC) & Diet Supplementary market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Over the Counter (OTC) & Diet Supplementary and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Over the Counter (OTC) & Diet Supplementary. This report presents a comprehensive overview, market shares, and growth opportunities of Over the Counter (OTC) & Diet Supplementary market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Analgesic & Pain Relievers &nbsp;&nbsp;&nbsp; Dermatological Products &nbsp;&nbsp;&nbsp; Cough, Cold and Flu Products &nbsp;&nbsp;&nbsp; Vitamin Supplements &nbsp;&nbsp;&nbsp; Mineral Supplements &nbsp;&nbsp;&nbsp; Ophthalmic Products Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Bayer AG &nbsp;&nbsp;&nbsp; Merck KGaA &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Alkem Laboratories &nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Sun Pharma &nbsp;&nbsp;&nbsp; Allergan Key Questions Addressed in this Report What is the 10-year outlook for the global Over the Counter (OTC) & Diet Supplementary market? What factors are driving Over the Counter (OTC) & Diet Supplementary market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Over the Counter (OTC) & Diet Supplementary market opportunities vary by end market size? How does Over the Counter (OTC) & Diet Supplementary break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Over the Counter (OTC) & Diet Supplementary Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Over the Counter (OTC) & Diet Supplementary by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Over the Counter (OTC) & Diet Supplementary by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Over the Counter (OTC) & Diet Supplementary Segment by Type &nbsp;2.2.1 Analgesic & Pain Relievers &nbsp;2.2.2 Dermatological Products &nbsp;2.2.3 Cough, Cold and Flu Products &nbsp;2.2.4 Vitamin Supplements &nbsp;2.2.5 Mineral Supplements &nbsp;2.2.6 Ophthalmic Products &nbsp;2.3 Over the Counter (OTC) & Diet Supplementary Sales by Type &nbsp;2.3.1 Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Over the Counter (OTC) & Diet Supplementary Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Over the Counter (OTC) & Diet Supplementary Sale Price by Type (2020-2025) &nbsp;2.4 Over the Counter (OTC) & Diet Supplementary Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.5 Over the Counter (OTC) & Diet Supplementary Sales by Application &nbsp;2.5.1 Global Over the Counter (OTC) & Diet Supplementary Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Over the Counter (OTC) & Diet Supplementary Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Over the Counter (OTC) & Diet Supplementary Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Over the Counter (OTC) & Diet Supplementary Breakdown Data by Company &nbsp;3.1.1 Global Over the Counter (OTC) & Diet Supplementary Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Over the Counter (OTC) & Diet Supplementary Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Over the Counter (OTC) & Diet Supplementary Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Over the Counter (OTC) & Diet Supplementary Revenue by Company (2020-2025) &nbsp;3.2.2 Global Over the Counter (OTC) & Diet Supplementary Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Over the Counter (OTC) & Diet Supplementary Sale Price by Company &nbsp;3.4 Key Manufacturers Over the Counter (OTC) & Diet Supplementary Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Over the Counter (OTC) & Diet Supplementary Product Location Distribution &nbsp;3.4.2 Players Over the Counter (OTC) & Diet Supplementary Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Over the Counter (OTC) & Diet Supplementary by Geographic Region &nbsp;4.1 World Historic Over the Counter (OTC) & Diet Supplementary Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Over the Counter (OTC) & Diet Supplementary Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Over the Counter (OTC) & Diet Supplementary Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Over the Counter (OTC) & Diet Supplementary Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Over the Counter (OTC) & Diet Supplementary Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Over the Counter (OTC) & Diet Supplementary Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Over the Counter (OTC) & Diet Supplementary Sales Growth &nbsp;4.4 APAC Over the Counter (OTC) & Diet Supplementary Sales Growth &nbsp;4.5 Europe Over the Counter (OTC) & Diet Supplementary Sales Growth &nbsp;4.6 Middle East & Africa Over the Counter (OTC) & Diet Supplementary Sales Growth 5 Americas &nbsp;5.1 Americas Over the Counter (OTC) & Diet Supplementary Sales by Country &nbsp;5.1.1 Americas Over the Counter (OTC) & Diet Supplementary Sales by Country (2020-2025) &nbsp;5.1.2 Americas Over the Counter (OTC) & Diet Supplementary Revenue by Country (2020-2025) &nbsp;5.2 Americas Over the Counter (OTC) & Diet Supplementary Sales by Type (2020-2025) &nbsp;5.3 Americas Over the Counter (OTC) & Diet Supplementary Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Over the Counter (OTC) & Diet Supplementary Sales by Region &nbsp;6.1.1 APAC Over the Counter (OTC) & Diet Supplementary Sales by Region (2020-2025) &nbsp;6.1.2 APAC Over the Counter (OTC) & Diet Supplementary Revenue by Region (2020-2025) &nbsp;6.2 APAC Over the Counter (OTC) & Diet Supplementary Sales by Type (2020-2025) &nbsp;6.3 APAC Over the Counter (OTC) & Diet Supplementary Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Over the Counter (OTC) & Diet Supplementary by Country &nbsp;7.1.1 Europe Over the Counter (OTC) & Diet Supplementary Sales by Country (2020-2025) &nbsp;7.1.2 Europe Over the Counter (OTC) & Diet Supplementary Revenue by Country (2020-2025) &nbsp;7.2 Europe Over the Counter (OTC) & Diet Supplementary Sales by Type (2020-2025) &nbsp;7.3 Europe Over the Counter (OTC) & Diet Supplementary Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Over the Counter (OTC) & Diet Supplementary by Country &nbsp;8.1.1 Middle East & Africa Over the Counter (OTC) & Diet Supplementary Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Over the Counter (OTC) & Diet Supplementary Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Over the Counter (OTC) & Diet Supplementary Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Over the Counter (OTC) & Diet Supplementary Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Over the Counter (OTC) & Diet Supplementary &nbsp;10.3 Manufacturing Process Analysis of Over the Counter (OTC) & Diet Supplementary &nbsp;10.4 Industry Chain Structure of Over the Counter (OTC) & Diet Supplementary 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Over the Counter (OTC) & Diet Supplementary Distributors &nbsp;11.3 Over the Counter (OTC) & Diet Supplementary Customer 12 World Forecast Review for Over the Counter (OTC) & Diet Supplementary by Geographic Region &nbsp;12.1 Global Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Region &nbsp;12.1.1 Global Over the Counter (OTC) & Diet Supplementary Forecast by Region (2026-2031) &nbsp;12.1.2 Global Over the Counter (OTC) & Diet Supplementary Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Over the Counter (OTC) & Diet Supplementary Forecast by Type (2026-2031) &nbsp;12.7 Global Over the Counter (OTC) & Diet Supplementary Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Bayer AG &nbsp;13.1.1 Bayer AG Company Information &nbsp;13.1.2 Bayer AG Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.1.3 Bayer AG Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Bayer AG Main Business Overview &nbsp;13.1.5 Bayer AG Latest Developments &nbsp;13.2 Merck KGaA &nbsp;13.2.1 Merck KGaA Company Information &nbsp;13.2.2 Merck KGaA Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.2.3 Merck KGaA Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Merck KGaA Main Business Overview &nbsp;13.2.5 Merck KGaA Latest Developments &nbsp;13.3 Novartis &nbsp;13.3.1 Novartis Company Information &nbsp;13.3.2 Novartis Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.3.3 Novartis Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Novartis Main Business Overview &nbsp;13.3.5 Novartis Latest Developments &nbsp;13.4 Johnson & Johnson &nbsp;13.4.1 Johnson & Johnson Company Information &nbsp;13.4.2 Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.4.3 Johnson & Johnson Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Johnson & Johnson Main Business Overview &nbsp;13.4.5 Johnson & Johnson Latest Developments &nbsp;13.5 GlaxoSmithKline &nbsp;13.5.1 GlaxoSmithKline Company Information &nbsp;13.5.2 GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.5.3 GlaxoSmithKline Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 GlaxoSmithKline Main Business Overview &nbsp;13.5.5 GlaxoSmithKline Latest Developments &nbsp;13.6 Alkem Laboratories &nbsp;13.6.1 Alkem Laboratories Company Information &nbsp;13.6.2 Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.6.3 Alkem Laboratories Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Alkem Laboratories Main Business Overview &nbsp;13.6.5 Alkem Laboratories Latest Developments &nbsp;13.7 Teva Pharmaceutical Industries &nbsp;13.7.1 Teva Pharmaceutical Industries Company Information &nbsp;13.7.2 Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.7.3 Teva Pharmaceutical Industries Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Teva Pharmaceutical Industries Main Business Overview &nbsp;13.7.5 Teva Pharmaceutical Industries Latest Developments &nbsp;13.8 Pfizer &nbsp;13.8.1 Pfizer Company Information &nbsp;13.8.2 Pfizer Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.8.3 Pfizer Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Pfizer Main Business Overview &nbsp;13.8.5 Pfizer Latest Developments &nbsp;13.9 Sun Pharma &nbsp;13.9.1 Sun Pharma Company Information &nbsp;13.9.2 Sun Pharma Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.9.3 Sun Pharma Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Sun Pharma Main Business Overview &nbsp;13.9.5 Sun Pharma Latest Developments &nbsp;13.10 Allergan &nbsp;13.10.1 Allergan Company Information &nbsp;13.10.2 Allergan Over the Counter (OTC) & Diet Supplementary Product Portfolios and Specifications &nbsp;13.10.3 Allergan Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Allergan Main Business Overview &nbsp;13.10.5 Allergan Latest Developments 14 Research Findings and Conclusion

Report	Global Over the Counter (OTC) & Diet Supplementary Market Growth 2025-2031
Selected License	Single ID:LPI23068

Buyer Information

Order Summary